Posted by AGORACOM-JC
at 8:52 AM on Wednesday, March 3rd, 2021
Announced the appointment of Joseph Braganza to the role of Senior Vice President, Head of M&A.
Mr. Braganza joins the senior leadership team with a mandate to lead Novamind’s M&A strategy, accelerating the Company’s expansion plans for its network of clinics, retreats and clinical research sites.
TORONTO, ON / March 3, 2021 / Novamind Inc.,(CSE:NM)(OTC PINK:NVMDF) (“Novamind” or the “Company”), a leading mental health company specialized in psychedelic medicine, announces the appointment of Joseph Braganza to the role of Senior Vice President, Head of M&A. Mr. Braganza joins the senior leadership team with a mandate to lead Novamind’s M&A strategy, accelerating the Company’s expansion plans for its network of clinics, retreats and clinical research sites.
Joseph has gained tenure as a M&A specialist and strategist, building sustainable programmatic M&A approaches for high-growth organizations. Leveraging over 20 years of professional experience, Joseph recently led the M&A group as Vice President, Business and Corporate Development at Canadian Addiction Treatment Centres (CATC), a consolidator of outpatient addiction treatment clinics that currently operates over 70 clinics and an inpatient residential treatment facility. Joseph previously held senior M&A roles at People Corp. (acquired by Goldman Sachs Merchant Banking), Rexall Health Solutions (a subsidiary of McKesson Corp.) and Deloitte.
“I am deeply committed to Novamind’s vision to scale their operating model for psychedelic medicine,” Braganza commented. “Facilitating greater access to these breakthrough treatments is critical in helping people find new ways to improve their mental health. I look forward to working with the leadership team as we pursue Novamind’s vision.”
Yaron Conforti, CEO and Director of Novamind added, “We’re excited to announce Joseph’s appointment to lead our M&A team. Joseph’s experience acquiring and integrating businesses, combined with his expertise in the mental health sector make him uniquely positioned to contribute to Novamind’s strategic growth plans.”
Posted by AGORACOM-JC
at 10:51 AM on Tuesday, March 2nd, 2021
Draganfly to be the exclusive supplier of drones to Woz ED’s drone program across its national K-12 curriculum
Expected deployment of approximately 3000 drones in 2021,Drone design and technical product advisory by Steve Wozniak’s team for proprietary Woz ED drones and drone related products,Collaboration and partnership in a fully funded international innovation center.
Los Angeles, CA, March 02, 2021 — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), award-winning, industry-leading drone solutions, and systems developer, today announced an exclusive strategic partnership with Woz ED, Steve Wozniak’s K-12 Education program.
Partnership scope includes
Draganfly to be the exclusive supplier of drones to Woz ED’s drone program across its national K-12 curriculum with the expected deployment of approximately 3000 drones in 2021,
Drone design and technical product advisory by Steve Wozniak’s team for proprietary Woz ED drones and drone related products,
Collaboration and partnership in a fully funded international innovation center.
The partnership will bring additional product development to Draganfly’s current and future pipeline in addition to re-imagining the future of innovation for drone technologies.
Inspired by Steve Wozniak, the co-founder of Apple (NASDAQ: AAPL), Woz ED provides a personalized approach to nurturing an engineering mindset through hands-on projects.
Woz ED is a model for incorporating the engineering process in the K-12 classroom and accelerating the path to employment for students who choose drones as a career. Students start with an introduction to aviation in Kindergarten and transition to physics of flight and flight skills in middle school. Students may choose elective courses in the Junior and Senior year to enroll in a drone course where students learn the engineering behind a drone, as well as earn their certification. The certification will make the students employable as they leave high school.
The Association of Unmanned Vehicle Systems International projected more than 100,000 new jobs in unmanned aircraft by 2025.
Draganfly will be the exclusive provider of drones as part of the Woz ED qualified for flight curriculum under their STEM programs. Students will gain hands-on experience piloting, and spotting for drone missions, design, and building for drone systems. Draganfly will also help develop further curriculum, career path development and field training for Woz ED students.
“Having an industry leader like Draganfly as a partner will give our kids the opportunity to learn from the best with real life experience and expertise,” said Steve Wozniak, Co- founder of Apple Inc.
“The military, energy, entertainment, real estate, agriculture, delivery, emergency response and construction sectors have embraced the power and the potential of drone technology, and NASA just landed Ingenuity on Mars! The industry-leading expertise Draganfly brings to this partnership amplifies our offerings in both curriculum and hardware as we expose young people to these booming career opportunities,” said Karen Young, CEO of Woz ED
“It has been said that Steve Wozniak designed Apple’s first products, the Apple I and II because they didn’t exist and he wanted to use them,” said Cameron Chell, CEO of Draganfly. “We are incredibly honored to be working with Steve and the team at Woz ED because of their bold, disruptive innovation and way of approaching challenges with technology.”
Posted by AGORACOM-JC
at 10:20 AM on Tuesday, March 2nd, 2021
Experienced a significant surge in online demand for its products and has launched its own Amazon Brand Store on Amazon.com.
The new Else Nutrition online store front provides an improved user experience enabling seamless customer journeys in product purchase, alongside a growing product assortment while better communicating the Else brand story.
VANCOUVER, BC , March 2, 2021 –ELSE NUTRITION HOLDINGS INC.(TSXV: BABY ) (OTCQX: BABYF ) (FSE: 0YL ) (“Else” or the “Company”) the Plant-Based baby, toddler and children nutrition company announces today that it has experienced a significant surge in online demand for its products and has launched its own Amazon Brand Store on Amazon.com. The new Else Nutrition online store front provides an improved user experience enabling seamless customer journeys in product purchase, alongside a growing product assortment while better communicating the Else brand story.
“This takes us to the next level on Amazon,” said Hamutal Yitzhak , CEO and Co-Founder of Else Nutrition. “We’ve already been seeing great response on the platform, and this combination of enhanced customer experience and access to greater ad tools, enable us to scale much faster. We will continue to build our brand and boost visibility on Amazon,” she added.
Else Plant-Based Complete Toddler Nutrition was a #1 Best Seller on Amazon in the New Releases for the Baby/Toddler Formula category in Fall 2020. The 2-pack format, which was recently released, has already become the top seller in Amazon’s New Releases in the Baby Powder formula category.
Posted by AGORACOM-JC
at 9:32 AM on Tuesday, March 2nd, 2021
Announce the appointment of veteran healthcare industry executive Paul Karam as Sales and Marketing Director, Europe, Middle East & Africa
Initially, Mr. Karam will be supporting the rollout and expansion in Turkey, Saudi Arabia, The United Arab Emirates and South Africa
He will also be responsible for new ventures and partnerships across the MEA Region and developing and executing the company marketing strategy in the EMEA region.
MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX), a global leader in teledermatology, is pleased to announce the appointment of veteran healthcare industry executive Paul Karam as Sales and Marketing Director, Europe, Middle East & Africa (“EMEA”), effective immediately. Mr. Karam will be reporting to the Managing Director for the EMEA region and strengthening the MedX global footprint in general and EMEA presence in particular.
Mr. Karam holds a master’s degree in Biomedical Engineering from the University of Surrey in the United Kingdom. He brings 20 plus years of experience in the health care industry, where he has held several leading roles within multinational companies covering Central and Eastern Europe, Turkey, the Middle East, Africa and Pakistan markets. He has a career history with Medtronic, Molnlycke, Stryker, and several other global companies.
“Mr. Karam’s strong experience and skills will be of high added value to our overall strategy in the region, as he helps develop the EMEA region with a specific focus on Turkey, the Middle East and African sub-regions. Mr. Karam will play an integral part in accelerating MedX’s revenue growth prospects by activating his already well-established medical device distributors network to the benefit of MedX’s skin assessment telemedicine technology in the region,” said Mr. Naman Demaghlatrous, Managing Director for EMEA.
Initially, Mr. Karam will be supporting the rollout and expansion in Turkey, Saudi Arabia, The United Arab Emirates and South Africa. He will also be responsible for new ventures and partnerships across the MEA Region and developing and executing the company marketing strategy in the EMEA region.
“We are pleased to welcome Paul to the MedX team. We are fortunate to attract a person of his calibre, and I think it speaks to the strength of our offering and the opportunity it presents in the EMEA market,” stated Michael Druhan, President of Dermatological Services & Products.
Posted by AGORACOM-JC
at 4:17 PM on Monday, March 1st, 2021
Last week we introduced you to ORTHO Regenerative Technologies, a cutting-edge med tech firm that uses its proprietary RESTORE technology platform to dramatically improve the success rate of orthopedic and sports medicine surgeries.
In layman’s terms, that means company has a wonder delivery platform that delivers biologics – drugs made from biological processes – to repair soft tissues in the human body.
Now the firm has appointed Patrick O’Donnell to its board of directors.
O’Donnell comes with significant company-building experience
He will prove crucial in putting this healthcare pioneer on-track for a NASDAQ listing
Claude LeDuc, Ortho’s CEO, breaks down the appointment:
Posted by AGORACOM-JC
at 2:35 PM on Monday, March 1st, 2021
PlantX Life Inc. (VEGA: CSE) (PLTXF: OTCQB) announces massive partnerships With Alicia Silverstone and Venus Williams. Did we mention that Russell Peters attended the AGM?
Posted by AGORACOM-JC
at 10:00 AM on Monday, March 1st, 2021
Combination of Loop technologies with Maitri platform has potential to create new paradigm in $120 Billion PPE market.
Announced the signing of a letter of intent (LOI) for the grant of a non-exclusive license to Maitri Health Technologies Corp. (CSE: MTEC) for various aspects of Loop’s technology in return for CDN$2,000,000 in cash and common shares as well as a revenue-sharing arrangement.
Maitri Health Technologies is focused on modernizing healthcare systems for a post-pandemic world.
Global events in 2020 identified the need for long-term security in both healthcare and the workplace.
VANCOUVER, BC , March 1, 2021 – Loop Insights Inc. (TSXV: MTRX) (OTCQB: RACMF) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue tracing to the brick and mortar space, is pleased to announce the signing of a letter of intent (LOI) for the grant of a non-exclusive license to Maitri Health Technologies Corp. (CSE: MTEC) for various aspects of Loop’s technology in return for CDN$2,000,000 in cash and common shares as well as a revenue-sharing arrangement.
Maitri Health Technologies is focused on modernizing healthcare systems for a post-pandemic world. Global events in 2020 identified the need for long-term security in both healthcare and the workplace. Maitri is a global platform for healthcare supply security providing a reliable source of certified PPE (personal protective equipment) and testing solutions through an onshore manufacturing model. This model has led to the creation of innovative and industry-leading products integrated with technology to help track, trace, and enable safer workplaces and communities. Maitri’s vision for the future is for safe workplaces and institutions to enable economies to operate uninterrupted.
The global market for PPE is expected to exceed USD$123 Billion by 2027 according to Grandview Research . The global workplace safety market is expected to grow to USD$19.9 Billion by 2025 according to Research and Markets .
The combination of Loop’s technologies with Maitri’s unique products has the potential to create a comprehensive offering for PPE and technology that will provide the foundation for safer, more protected workplaces and communities.
Loop Insights CEO Rob Anson stated: “COVID-19 created an immediate need for PPE that also immediately became a highly disorganized and fragmented market of middlemen and brokers with often questionable sources. Maitri’s ability to establish secure access and trusted distribution to key PPE products through a platform positions them to quickly become a strong force in the industry. This licensing arrangement will provide the ability to add venue, business and building protection to their offering, leading to brand new opportunities and revenue models.”
LICENSING ARRANGEMENT TO COMBINE PPE, ARTIFICIAL INTELLIGENCE AND PROPTECH IN FIRST-EVER AND FULLY SCALABLE OFFERING
Maitri’s PPE line of products combined with Loop Insights technology represents the convergence of a powerful PPE, AI, and Proptech offering that enables operators, businesses and building owners to reopen and protect all constituents with a documented process from verified PPE to venue management and artificial intelligence-driven marketing opportunities. This combined protocol enables physical buildings to fully reopen, generate revenue, and remain viable assets under end-to-end protection.
As a result, Loop Insights gains access to another major industry component that is essential to the safe re-opening of the global economy and society.
“Our relationship with Loop technology will create the opportunity to deliver a more complete safety protocol along with our existing products and offerings,” said Andrew Morton , CEO of Maitri. “We’re well-positioned to play a significant role supporting a path to global economic recovery.”
TERMS OF THE LOI
Loop will license the following technology:
AI Data Insights Portal;
SmarTap Check-in Technology; and
Digital Wallet Pass Technology.
In exchange for the license, Loop will receive a total value of $2,000,000 in a combination of both:
Cash $250,000 ;
Common Shares $1,750,000 ; and
Revenue Share (terms to be determined)
Both parties have agreed to a 30-day closing period for a definitive agreement, the terms of which are subject to the approval by the Board of Directors of both companies.
Maitri Health Technologies Corp. (CSE: MTEC, FRA: D84) is a global platform for healthcare supply security. Our mission is to enhance safety and quality of life, and keep organizations and economies running. Maitri provides a reliable source of innovative, certified personal protective equipment and testing solutions through an onshore manufacturing model. Our stable, scalable supply chain is integrated with unique digital technology to deliver a comprehensive healthcare supply platform. For more information: https://maitrihealth.ca/ or [email protected]
About Loop Insights
Loop Insights Inc. is a Vancouver -based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada , the US, the UK, Latin America , Australia , Japan , and Indonesia . Loop’s products and services are backed by Amazon’s Partner Network.
Tags: AI, Amazon, artificial intelligence, Big data, Bitcoin, covid19 Posted in Loop Insights Inc. | Comments Off on Loop Insights $MTRX $RACMF Signs Letter of Intent for $2,000,000 Licensing Deal with Maitri Health Technologies to Combine #PPE, Artificial Intelligence and #Proptech In First-Ever Globally Scalable Offering $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca
Posted by AGORACOM-JC
at 9:50 AM on Monday, March 1st, 2021
Liquid Avatar name and symbol change better reflects Company’s corporate branding
Announced that it has changed its name from KABN Systems NA Holdings Corp. to Liquid Avatar Technologies Inc. (www.liquidavatartechnologies.com) and its ticker symbol from KABN to LQID
TORONTO, ON / March 1, 2021 /KABN Systems NA Holdings Corp. (CSE:KABN)(“KABN” or the “Company“) is pleased to announce that it has changed its name from KABN Systems NA Holdings Corp. to Liquid Avatar Technologies Inc. (www.liquidavatartechnologies.com) and its ticker symbol from KABN to LQID. Subject to approval by the Canadian Securities Exchange (the “CSE”), the Company expects the name and symbol change to take effect for trading purposes on March 3, 2021 when its common shares will begin trading on the CSE under the new name, CUSIP number and new ticker symbol.
On February 18, 2021, the Company launched the first phase of its flagship product, the Liquid Avatar (www.liquidavatar.com) app in the Apple Store and Google Play.
Like search, online communications and browser usage, digital identity is addressable to up to 100% of the online market and is a very early-stage market opportunity, with the potential to reach up to 400 Million people in North America and over 5 Billion people online globally.
According to Statista.com, over 79% of video game users in the US are over the age of 18 with a surprising 41% over the age of 34, showing that video gaming and character creation is widespread through all age categories. Using Liquid Avatar, users are able to select from 1000’s of combinations of facial features to create their perfect digital, “cartoon-like” representations of themselves – all at no cost. Future releases of Liquid Avatar will allow users to upload their own digital icon images and create even more realistic versions of themselves as the Company explores new technologies that allow 3D animation and facial embedding on video characters.
Posted by AGORACOM-JC
at 8:29 AM on Monday, March 1st, 2021
$1.29 million in fiscal second quarter revenue
Clinics see continued surge in demand for mental health services
Ongoing expansion of clinic capacity
TORONTO, ON / March 1, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF) (“Novamind” or “the Company”), a leading mental health company specialized in psychedelic medicine, today reported its fiscal second quarter results for the three months ended December 31, 2020 (“Fiscal Q2 2021″). The Company’s fiscal year-end is June 30th. All results are reported under International Financial Reporting Standards (“IFRS”) and in Canadian dollars, unless otherwise specified.
Fiscal Q2 2021 Highlights and Subsequent Developments
Financing and Public Listing
Novamind successfully closed an oversubscribed $10,000,000 financing on November 23rd, 2020. The funds were made available to the Company upon the completion of its reverse takeover (“RTO”) transaction and conditional listing approval from the Canadian Securities Exchange (“CSE”). The company ended the quarter with a cash balance of $10,868,742. With its strong cash position, Novamind is well-positioned to execute on its growth strategy to expand its network of mental health clinics, retreats and clinical research sites.
On January 5th, 2021, Novamind began trading on the CSE under the stock symbol “NM”. Less than two months after going public on the CSE, Novamind achieved the milestone of being included in the underlying index of the Horizons Psychedelic Stock Index ETF (NEO: PSYK) through a “Fast Entry” category, further increasing its profile with retail and institutional investors in the psychedelic medicine sector.
The Company announced on February 19th, 2021, that its common shares commenced trading under the symbol “NVMDF” on the OTC Market. In the near future, Novamind intends to apply to list its common shares on the OTCQB Market, an established marketplace in the United States for promising, innovative companies.
Operational Highlights
On January 28th, 2021, Novamind announced that it had reached two significant milestones at its Cedar Psychiatry mental health clinics: administering over 5,000 ketamine treatments since its opening in 2016, and administering over 2,000 Spravato™ treatments since the product became available in 2019. These milestones position Novamind as one of North America’s top providers of ketamine-assisted psychotherapy and Spravato™.
On January 13th, 2021, the Company announced the expansion and optimization of its Layton, Utah clinic. The redesigned Layton Clinic now offers improved treatment rooms to accommodate a higher number of ketamine and Spravato™ treatments. The Layton Clinic expansion comes in response to a significant increase in demand for ketamine therapies across Novamind’s mental health clinics. In 2020 alone, the Cedar Psychiatry clinic network facilitated over 20,000 client visits, an increase of over 100 percent compared to the same period in 2019.
On January 19th, 2021, Novamind announced the expansion of its leadership team with the appointment of Pierre Bou-Mansour, P.Eng., to the role of Chief Operating Officer. Mr. Bou-Mansour assumes the responsibility for ensuring operational excellence as Novamind develops its network of clinics, retreats, and research sites. An accomplished senior executive and leader, he brings a wealth of experience managing large and complex healthcare organizations. Prior to joining Novamind, Pierre served as the Chief Operating Officer of LifeLabs, a diagnostic laboratory services company he helped to scale into an industry leader with 5,700 employees and 370 patient access sites in Canada. Most recently, he served as the Chief Laboratory Operations Officer of Public Health Ontario, serving Canada’s largest province with over 14 million residents. In this role, Bou-Mansour successfully led the expansion of Public Health Ontario’s testing capacity for the COVID-19 response.
Strategic Investment in Bionomics
On February 11th, 2021, the Company announced that it had made a strategic investment of AU$827,486 (approximately CAN$810,000), in Bionomics Limited (“Bionomics”) (ASX: BNO, OTCQB: BNOEF, Germany: AU000000BNO5), a biopharmaceutical company dedicated to developing better treatments for central nervous system disorders. In addition, Cedar Clinical Research, a wholly owned subsidiary of Novamind, will be evaluated by Bionomics as a clinical research site to conduct Bionomics’ phase IIb clinical trial examining BNC210, a drug that has received Fast Track Designation from the U.S. Food and Drug Administration for the treatment of post-traumatic stress disorder (PTSD).
Impact of COVID-19
Novamind has not been significantly affected by the COVID-19 pandemic. As reported across multiple media outlets, the COVID-19 pandemic has resulted in a significant increase in the incidence of mental health problems, in particular anxiety and depression, conditions that are commonly treated by Novamind. The Company’s Cedar Psychiatry network of clinics continues to experience steady demand for mental health services, and this demand is anticipated to continue despite COVID-related restrictions.
Financial Highlights and Selected Consolidated Financial Information
In Fiscal Q2 2021, Novamind reported revenue of $1,288,828 primarily composed of patient services revenue from its network of four Cedar Psychiatry outpatient mental health clinics in Utah. This represents a 47 percent increase over the previous quarter ended September 30th, 2020.
The Company reported a net loss of $3,567,883 for the three months ended December 31st, 2020, as compared to a net loss of $493,614 for the prior quarter ended September 30th, 2020. The net loss for the second fiscal quarter was primarily due to expenses related to the Company’s listing on the CSE, and funding of capacity expansion at its Cedar Psychiatry clinics. This includes consulting expenses of $416,268, professional fees of $450,419, salaries and wages of $791,078, office and general expenses of $87,368, advertising and promotion expenses of $236,650, and stock-based compensation of $664,814. Additionally, there was $1,379,144 in RTO transaction costs in the quarter.
The following table presents selected financial information from the Company’s unaudited condensed interim financial statements for the three and six months ended December 31st, 2020, and periods ended December 31st, 2019.
The following information should be read in conjunction with the financial statements and management’s discussion and analysis, which are available under the Company’s SEDAR profile at www.sedar.com.
About Novamind
Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit novamind.ca.
This news release contains forward-looking statements. All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations including the risks detailed from time to time in the Company’s public disclosure. The reader is cautioned not to place undue reliance on any forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable laws.
Posted by AGORACOM-JC
at 1:13 PM on Saturday, February 27th, 2021
PlantX Life Inc. (VEGA: CSE) (PLTXF: OTCQB) announces massive partnerships With Alicia Silverstone and Venus Williams. Did we mention that Russell Peters attended the AGM?
